3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Stomach Neoplasms
7
Esophageal Neoplasms
6
Inflammatory Breast Neoplasms
4
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Sarcoma
1
Her2-Positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
Irinotecan
6
Temozolomide
5
Cyclophosphamide
5
Vincristine
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
palbociclib
3
X-Rays
3
Phantoms, Imaging
3
Gemcitabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
ivosidenib
2
ganitumab
2
eribulin
2
cixutumumab
2
cabozantinib
2
abemaciclib
2
Vemurafenib
2
Specimen Handling
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Peripheral Blood Stem Cell Transplantation
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
FANG vaccine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Ewing
×
Epirubicin
×
Clear all
No trials found.